A 24-year-old man and his mother arrive for a psychiatric evaluation. She is concerned about his health and behavior ever since he dropped out of graduate school and moved back home 8 months ago. He is always very anxious and preoccupied with thoughts of school and getting a job. He also seems to behave very oddly at times such as wearing his winter jacket in summer. He says that he hears voices but he can not understand what they are saying. When prompted he describes a plot to have him killed with poison seeping from the walls. Today, his heart rate is 90/min, respiratory rate is 17/min, blood pressure is 110/65 mm Hg, and temperature is 36.8°C (98.2°F). On physical exam, he appears gaunt and anxious. His heart has a regular rate and rhythm and his lungs are clear to auscultation bilaterally. CMP, CBC, and TSH are normal. A urine toxicology test is negative. What is the most likely diagnosis?
A 27-year-old woman comes to the physician because she has been hearing voices in her apartment during the past year. She also reports that she has been receiving warning messages in newspaper articles during this period. She thinks that “someone is trying to kill her”. She avoids meeting her family and friends because they do not believe her. She does not use illicit drugs. Physical examination shows no abnormalities. Mental status examination shows a normal affect. Which of the following is the most appropriate long-term treatment?
A 31-year-old woman comes to the physician because she thinks that her “right wrist is broken.” She says that she has severe pain and that “the bone is sticking out.” She has not had any trauma to the wrist. Her medical records indicate that she was diagnosed with schizophrenia 2 years ago and treated with olanzapine; she has not filled any prescriptions over the past 4 months. Three weeks ago, she stopped going to work because she “did not feel like getting up” in the morning. Vital signs are within normal limits. Physical examination of the right wrist shows no visible injury; there is no warmth, swelling, or erythema. Range of motion is limited by pain. On mental status examination, she has a flat affect. Her speech is pressured and she frequently changes the topic. She has short- and long-term memory deficits. Attention and concentration are poor. There is no evidence of suicidal ideation. Urine toxicology screening is negative. An x-ray of the wrist shows no abnormalities. Which of the following is the most appropriate response to this patient's concerns?
A 22-year-old man with a history of schizophrenia presents to the emergency room escorted by police. The officers state that the patient was found at a local mall, threatening to harm people in the parking lot, screaming at them, and chasing them. The patient states that those people were agents of the government sent to kill him. The patient is agitated and seems to be responding to internal stimuli. He refuses treatment and states that he wants to leave or he will hurt the hospital staff and other patients. Which of the following is the most appropriate next step in management?
A 45-year-old obese man is evaluated in a locked psychiatric facility. He was admitted to the unit after he was caught running through traffic naked while tearing out his hair. His urine toxicology screening was negative for illicit substances and after careful evaluation and additional history, provided by his parents, he was diagnosed with schizophrenia and was treated with aripiprazole. His symptoms did not improve after several dosage adjustments and he was placed on haloperidol, but this left him too lethargic and slow and he was placed on loxapine. After several dosage adjustments today, he is still quite confused. He describes giant spiders and robots that torture him in his room. He describes an incessant voice screaming at him to run away. He also strongly dislikes his current medication and would like to try something else. Which of the following is indicated in this patient?
A 31-year-old woman comes to the emergency department requesting an abortion. She hears voices telling her that she needs ""to undergo a cleanse."" She experiences daytime sleepiness because she repeatedly wakes up at night. She says that she is no longer interested in activities that she used to enjoy. About 2 months ago, her psychiatrist switched her medication from aripiprazole to risperidone because it was not effective even at maximum dose. Vital signs are within normal limits. Mental status examination shows accelerated speech, and the patient regularly switches the conversation to the natural habitat of bees. A urine pregnancy test is positive. Toxicology screening is negative. Pelvic ultrasonography shows a pregnancy at an estimated 15 weeks' gestation. Following admission to the hospital, which of the following is the most appropriate next step in management?
A 16-year-old boy is brought in to a psychiatrist's office by his mother for increasingly concerning erratic behavior. Her son has recently entered a new relationship, and he constantly voices beliefs that his girlfriend is cheating on him. He ended his last relationship after voicing the same beliefs about his last partner. During the visit, the patient reports that these beliefs are justified, since everyone at school is “out to get him.” He says that even his teachers are against him, based on their criticism of his schoolwork. His mother adds that her son has always held grudges against people and has always taken comments very personally. The patient has no psychiatric history and is in otherwise good health. What condition is this patient genetically predisposed for?
A 27-year-old woman is brought to the office at the insistence of her fiancé to be evaluated for auditory hallucinations for the past 8 months. The patient’s fiancé tells the physician that the patient often mentions that she can hear her own thoughts speaking aloud to her. The hallucinations have occurred intermittently for at least 1-month periods. Past medical history is significant for hypertension. Her medications include lisinopril and a daily multivitamin both of which she frequently neglects. She lost her security job 7 months ago after failing to report to work on time. The patient’s vital signs include: blood pressure 132/82 mm Hg; pulse 72/min; respiratory rate 18/min, and temperature 36.7°C (98.1°F). On physical examination, the patient has a flat affect and her focus fluctuates from the window to the door. She is disheveled with a foul smell. She has difficulty focusing on the discussion and does not quite understand what is happening around her. A urine toxicology screen is negative. Which of the following is the correct diagnosis for this patient?
A 24-year-old man is brought to the doctor's office by his mother because the patient believes aliens have begun to read his mind and will soon have him performing missions for them. The patient's mother says that the delusions have been intermittently present for periods of at least 1-month over the past year. When he is not having delusions, she says he still lacks expression and has no interest in socializing with his friends or going out. He has no past medical history and takes no prescription medications. The patient has smoked 1 pack of cigarettes daily for the past 10 years. Since the disturbance, he has not been able to maintain employment and lives at home with his mother. His vitals include: blood pressure 124/82 mm Hg, pulse 68/min, respiratory rate 14/min, temperature 37.3°C (99.1°F). On physical examination, the patient exhibits poor eye contact with a flat affect. His speech is circumferential, and he is currently experiencing bizarre delusions. The results from a urine drug screen are shown below: Amphetamine negative Benzodiazepine negative Cocaine negative GHB negative Ketamine negative LSD negative Marijuana negative Opioids negative PCP negative Which of the following is the correct diagnosis?
A 27-year-old man is brought to the emergency department from a homeless shelter because of bizarre behavior. He avoids contact with others and has complained to the supervising staff that he thinks people are reading his mind. Three days ago, he unplugged every electrical appliance on his floor of the shelter because he believed they were being used to transmit messages about him to others. The patient has schizophrenia and has been prescribed risperidone but has been unable to comply with his medications because of his unstable living situation. He is disheveled and malodorous. His thought process is disorganized and he does not make eye contact. Which of the following is the most appropriate long-term pharmacotherapy?
Explanation: ***Schizophrenia*** - The patient presents with **delusions** ("plot to have him killed"), **hallucinations** ("hears voices"), **disorganized thinking** (preoccupied with school and job but no progress made, wearing winter jacket in summer can be a sign of disorganized behavior), and **negative symptoms** (appears gaunt and anxious, social withdrawal, drop out of school). These symptoms have been present since he dropped out of graduate school 8 months ago, indicating a **duration of at least 6 months**. - The combination of these symptoms persisting for over 6 months, impacting his functioning, and absence of other medical or substance-related causes, is diagnostic of **schizophrenia**. *Substance-induced psychosis* - The **urine toxicology test is negative**, ruling out recent substance use as the cause of his psychotic symptoms. - The **chronicity** of symptoms (8 months) is less typical for acute substance-induced psychosis, which generally resolves more quickly after the substance is cleared. *Schizophreniform disorder* - Schizophreniform disorder involves the same symptoms as schizophrenia but with a **duration of at least 1 month but less than 6 months**. - The patient's symptoms have been present for **8 months**, exceeding the criteria for schizophreniform disorder. *Schizoaffective disorder* - Schizoaffective disorder requires the presence of a **major mood episode** (depressive or manic) concurrent with criteria A of schizophrenia. Additionally, **delusions or hallucinations for at least 2 weeks** must occur in the absence of a major mood episode at some point during the illness. - While the patient appears anxious, there is **no clear evidence of a persistent major depressive or manic episode** that would qualify for schizoaffective disorder. *Brief psychotic disorder* - Brief psychotic disorder is characterized by psychotic symptoms lasting **more than 1 day but less than 1 month**. - The patient's symptoms have been ongoing for **8 months**, far exceeding the duration for brief psychotic disorder.
Explanation: ***Quetiapine*** - This patient presents with **psychotic symptoms** (auditory hallucinations, delusions of persecution and reference) lasting over a year, consistent with **schizophrenia**. - **Quetiapine** is a **second-generation antipsychotic** (atypical antipsychotic) commonly used as a long-term treatment for schizophrenia due to its efficacy in managing positive and negative symptoms and typically favorable side effect profile compared to first-generation agents. *Lithium carbonate* - **Lithium** is primarily used as a **mood stabilizer** for bipolar disorder, particularly for managing manic and mixed episodes. - While it can have some antipsychotic effects, it is not the first-line long-term treatment for **schizophrenia** with prominent psychotic symptoms. *Fluphenazine* - **Fluphenazine** is a **first-generation antipsychotic** (typical antipsychotic) and is effective for positive symptoms of schizophrenia. - However, it has a higher risk of **extrapyramidal symptoms (EPS)** and **tardive dyskinesia** compared to second-generation antipsychotics, making second-generation agents often preferred for long-term treatment. *Clozapine* - **Clozapine** is a highly effective **second-generation antipsychotic** for **treatment-resistant schizophrenia** but is not a first-line agent for initial treatment due to significant side effects. - Its use is limited by the risk of **agranulocytosis**, requiring regular blood monitoring, and other serious side effects like myocarditis and seizures. *Midazolam* - **Midazolam** is a **benzodiazepine** used for acute sedation, anxiety, or insomnia due to its rapid onset and short duration of action. - It has no role in the long-term treatment of **psychotic disorders** like schizophrenia.
Explanation: ***“I cannot see any injury of your wrist and the physical exam as well as the x-ray don't show any injury. I imagine that feeling as if your wrist was broken may be very uncomfortable. Can you tell me more about what it feels like?”*** - This response **validates the patient's experience of pain and distress** while gently reorienting them to the objective findings (no physical injury). - It opens a dialog to explore the **patient's subjective experience** and build trust, which is crucial for addressing underlying psychiatric issues in a patient with schizophrenia. *“It seems as though you are having a schizophrenia relapse. If you don't follow my recommendations and take your medications, you will most likely have further and possibly more severe episodes.”* - This statement is **confrontational and judgmental**, potentially alienating the patient and making them less likely to engage in treatment. - Directly labeling a relapse and warning of future severity without first building rapport can trigger **defensiveness and non-compliance**. *I understand your concerns; however, your symptoms seem to be psychological in nature. I would be happy to refer you to a mental health professional.* - While accurate about the psychological nature of symptoms, this response **dismisses the patient's immediate physical complaint** and might make them feel unheard. - It prematurely jumps to a referral without fully exploring the current presentation or establishing a therapeutic alliance, which can be perceived as the physician "passing the buck." *I can imagine that you are uncomfortable. That certainly looks painful. Let's take care of this injury first and then we should talk about your problems getting up in the morning.* - This response **validates a non-existent injury**, reinforcing the patient's delusion and potentially diverting attention from the underlying psychiatric condition. - Prioritizing a non-existent injury would lead to inappropriate medical interventions and delay necessary psychiatric care. *You are clearly distressed. However, your tests do not suggest a physical problem that can be addressed with medications or surgery. I suggest that we meet and evaluate your symptoms on a regular basis.* - While acknowledging distress and the lack of physical pathology, this response is somewhat **vague and lacks a clear plan** for addressing the primary concern of perceived injury. - "Regular evaluation" without specific intent to explore the psychological component or re-initiate psychiatric treatment may not be sufficient for a patient experiencing a schizophrenia relapse.
Explanation: ***Begin treatment due to patient's lack of decision-making capacity.*** - The patient exhibits features of acute psychosis, including **paranoid delusions**, **hallucinations** (responding to internal stimuli), and **agitation**, which significantly impair his ability to make rational decisions about his care. - Due to the **imminent risk of harm to himself and others**, and his inability to understand the consequences of leaving, treatment is ethically and legally justified even without his consent under the principle of **parens patriae** and the duty to protect. *Let the patient leave against medical advice.* - Allowing the patient to leave against medical advice would expose others to potential harm given his threats and agitated state, and would neglect the physician's duty to protect. - A patient lacking **decision-making capacity** cannot validly refuse treatment, especially when there's a risk of harm to self or others. *Wait for a psychiatrist to determine patient capacity.* - While a psychiatric evaluation is crucial, the **immediate danger** posed by the patient's agitation and threats necessitates prompt intervention. - Delaying treatment to wait for a formal capacity assessment could compromise safety. The emergency physician can initially determine capacity for the purpose of urgent intervention. *Determine patient competency.* - **Competency** is a legal term determined by a court, whereas **capacity** is a clinical determination made by a physician. - The immediate clinical need is to assess and manage the patient's capacity to make medical decisions, not their legal competency. *Ask the police to escort the patient to jail.* - While the patient's actions are disruptive, his behavior stems from a medical condition (schizophrenia), making him a patient in need of medical care, not primarily a criminal. - Incarceration would not address the underlying acute psychiatric emergency and could worsen his condition or delay appropriate treatment.
Explanation: ***Clozapine*** - This patient has **treatment-resistant schizophrenia**, indicated by a lack of response to multiple trials of antipsychotics, including aripiprazole (atypical), haloperidol (typical), and loxapine (atypical). - **Clozapine** is the only antipsychotic proven effective for treatment-resistant schizophrenia, significantly reducing psychotic symptoms and suicidality. *Haloperidol* - Haloperidol is a **first-generation antipsychotic** that the patient has already tried and found to be too sedating and slow. - Continuing with haloperidol would likely result in persistent side effects and inadequate symptom control given his prior negative experience. *Olanzapine* - Olanzapine is a **second-generation atypical antipsychotic**; however, it is not typically indicated as a first-line treatment for treatment-resistant schizophrenia after failure of multiple agents. - While effective for schizophrenia, it would be less effective than clozapine in a patient who has failed several previous antipsychotic trials. *Chlorpromazine* - Chlorpromazine is a **first-generation antipsychotic** that carries a higher risk of sedation, extrapyramidal symptoms, and anticholinergic side effects. - It is unlikely to be more effective than haloperidol, which the patient already found too sedating and slow, and would not be the preferred choice for treatment-resistant schizophrenia. *Fluphenazine* - Fluphenazine is a **first-generation antipsychotic** with potent dopamine D2 receptor blockade, often leading to significant extrapyramidal side effects. - Like other first-generation antipsychotics, it is not indicated as the next step for treatment-resistant schizophrenia after failure of multiple trials.
Explanation: ***Clozapine therapy*** - This patient presents with **treatment-resistant psychosis** having failed aripiprazole at maximum dose and showing persistent symptoms despite 2 months on risperidone. She exhibits **auditory hallucinations**, **mood symptoms** (anhedonia, sleep disturbance), and **thought disorganization** (tangentiality), suggesting possible schizoaffective disorder. - **Clozapine is the gold standard treatment** for schizophrenia that has failed at least two adequate trials of other antipsychotics. It is the **only FDA-approved medication** specifically indicated for treatment-resistant schizophrenia. - While clozapine requires close monitoring for **agranulocytosis** (weekly CBC for 6 months, then biweekly), it can be used during pregnancy when benefits outweigh risks. The patient requires psychiatric stabilization, and clozapine offers the best chance of symptom control given her refractory illness. *Electroconvulsive therapy* - ECT is highly effective for severe psychiatric illness but is typically reserved for: **severe catatonia**, medication failures **including clozapine**, or situations requiring **rapid response** when medications are contraindicated. - This patient has not yet tried clozapine, which should be the next step before considering ECT. She does not have catatonia (insomnia and tangentiality are not catatonic features). - ECT would be appropriate if clozapine fails or is contraindicated, but it is not the most appropriate **next** step when a proven medication option remains untried. *Quetiapine therapy* - Quetiapine is another atypical antipsychotic, but simply switching to another non-clozapine antipsychotic after two failures is not the recommended approach for treatment-resistant schizophrenia. - The patient has already failed aripiprazole and shows insufficient response to risperidone, indicating the need for clozapine rather than another trial of a conventional atypical antipsychotic. *Lithium therapy* - Lithium is a mood stabilizer used primarily for bipolar disorder and can be used as augmentation in treatment-resistant psychosis. However, it is **not first-line monotherapy** for psychotic symptoms. - Lithium has **teratogenic risks** including Ebstein's anomaly when used in the first trimester, and requires careful therapeutic monitoring. Given that this patient is at 15 weeks gestation and needs antipsychotic control, clozapine monotherapy is more appropriate than introducing lithium. *Clomipramine therapy* - Clomipramine is a tricyclic antidepressant primarily used for **obsessive-compulsive disorder** and severe depression. It is not indicated for treatment-resistant psychosis. - While the patient has depressive features (anhedonia, sleep disturbance), her primary presentation is psychotic with treatment resistance, requiring antipsychotic optimization rather than antidepressant therapy.
Explanation: ***Schizophrenia*** - The patient's symptoms of **pervasive distrust**, **suspiciousness**, beliefs that others are "out to get him," and taking comments personally are characteristic of **paranoid personality disorder**. - **Paranoid personality disorder (PPD)** is considered part of the **schizotypal spectrum** or **cluster A personality disorders**, and individuals with PPD have a higher genetic predisposition to develop **schizophrenia** and other psychotic disorders. *Antisocial personality disorder* - This disorder is characterized by **disregard for and violation of the rights of others**, impulsivity, and lack of remorse, which are not the primary features described here. - While individuals with this disorder may exhibit manipulative behavior, their core issue is not paranoid ideation but rather a pattern of social irresponsibility and law-breaking. *Major depressive disorder* - This condition is characterized by **persistent sadness**, loss of interest or pleasure, and other vegetative symptoms, which are not present in this patient's presentation. - The patient's primary symptoms revolve around **paranoia and suspiciousness**, not mood disturbances. *Narcolepsy* - Narcolepsy is a **neurological condition** characterized by overwhelming daytime sleepiness and sudden attacks of sleep. - This diagnosis is entirely unrelated to the patient's psychological symptoms of paranoia and distrust. *Substance use disorder* - While substance use can sometimes induce paranoid thinking, the patient's long-standing history of **grudges** and taking comments personally, even prior to potential substance exposure (implied by no psychiatric history mentioned for substance abuse), suggests a more ingrained personality trait rather than solely substance-induced paranoia. - There is **no information provided about substance use**, making this a less likely primary condition or genetic predisposition.
Explanation: ***Schizophrenia*** - The patient exhibits core symptoms of schizophrenia, including **auditory hallucinations** (hearing thoughts speaking aloud), **disorganized thinking** (difficulty focusing, fluctuating focus), and **negative symptoms** (flat affect, disheveled, foul smell, loss of job due to poor function). These symptoms have been present for **at least 6 months** (8 months of hallucinations, 7 months of job loss), which meets the diagnostic criteria. - The duration of symptoms (over 6 months) differentiates it from schizophreniform disorder, and the absence of prominent mood episodes rules out schizoaffective disorder. *Schizoaffective disorder* - This diagnosis requires a **major mood episode** (depressive or manic) concurrent with Criterion A of schizophrenia, along with a period of **at least 2 weeks of delusions or hallucinations in the absence of prominent mood symptoms**. - While the patient has some signs of distress (lost job, disorganized), a full major mood episode is not described, and the primary symptoms are clearly psychotic. *Schizoid personality disorder* - This is characterized by a pervasive pattern of **detachment from social relationships** and a restricted range of emotional expression, often appearing indifferent to praise or criticism. - The patient's symptoms are primarily psychotic (hallucinations, disorganized thought), not just social withdrawal or emotional flatness. She doesn't necessarily avoid social contact, but her psychosis interferes with it. *Schizophreniform disorder* - This disorder presents with symptoms identical to schizophrenia but with a **duration of at least 1 month but less than 6 months**. - The patient's symptoms, particularly the auditory hallucinations, have been present for 8 months and are therefore outside the timeframe for schizophreniform disorder. *Schizotypal personality disorder* - This disorder involves a pervasive pattern of **social and interpersonal deficits** marked by acute discomfort with, and reduced capacity for, close relationships, as well as **cognitive or perceptual distortions** and eccentric behaviors. - While there may be some odd beliefs or magical thinking, **full-blown psychotic symptoms like prominent auditory hallucinations** (hearing thoughts speaking aloud) are generally not present as consistently or severely as seen in this patient, who meets criteria for a major psychotic disorder.
Explanation: ***Correct: Schizophrenia*** - The patient presents with **bizarre delusions** (positive symptom), **flat affect**, **lack of interest in socializing**, and **social withdrawal** (negative symptoms), characteristic of schizophrenia. - The symptoms have been present **intermittently over the past year**, with the mother noting that even when delusions are absent, the patient continues to exhibit negative symptoms (flat affect, social withdrawal). - This indicates **continuous signs of illness for at least 6 months** with **at least 1 month of active psychotic symptoms**, fulfilling **DSM-5 criteria** for schizophrenia. - The patient demonstrates **significant functional impairment** (unable to maintain employment), which is required for diagnosis. - **Substance-induced psychosis** is ruled out by negative urine drug screen. *Incorrect: Schizoaffective disorder* - Requires the presence of a **major mood episode (depressive or manic)** concurrent with psychotic symptoms for a substantial portion of the illness. - Psychotic symptoms must also persist for **at least 2 weeks in the absence of a major mood episode**. - This patient shows **no evidence of major mood symptoms** (no depression or mania described). *Incorrect: Schizotypal personality disorder* - Involves **cognitive or perceptual distortions** (odd beliefs, magical thinking) and eccentric behavior, but symptoms are typically **less severe** than frank psychosis. - Patients usually maintain **better baseline functioning** than those with schizophrenia. - This patient's **severe delusions, significant functional impairment**, and chronic deterioration are more consistent with schizophrenia than a personality disorder. *Incorrect: Schizoid personality disorder* - Characterized by **detachment from social relationships** and restricted emotional expression. - **Does not include psychotic symptoms** such as delusions or hallucinations. - This patient's bizarre delusions rule out this purely personality-based diagnosis. *Incorrect: Schizophreniform disorder* - Diagnosed when symptoms of schizophrenia are present for **1 to 6 months** (more than 1 month but less than 6 months). - This patient's symptoms have been present **over the past year**, exceeding the 6-month maximum duration for schizophreniform disorder. - The chronic nature and duration of symptoms establish the diagnosis of schizophrenia instead.
Explanation: ***Intramuscular risperidone*** - Given the patient's **non-compliance** due to an unstable living situation, a **long-acting injectable antipsychotic** like intramuscular risperidone is the most appropriate choice for long-term management. This ensures consistent medication delivery regardless of daily adherence. - This medication directly addresses the **positive symptoms of schizophrenia** (paranoia, disorganized thought) that are evident in the patient's bizarre behavior and delusional beliefs. *Intravenous propranolol* - Propranolol is a **beta-blocker** used to treat anxiety, hypertension, and tremors, but it is **not an antipsychotic** and does not address the core symptoms of schizophrenia. - It could potentially be used for symptom control like akathisia if present, but not as primary long-term pharmacotherapy for psychosis. *Intramuscular benztropine* - Benztropine is an **anticholinergic medication** primarily used to treat **extrapyramidal symptoms (EPS)** induced by antipsychotics (e.g., dystonia, parkinsonism). - It does not have antipsychotic effects and would not treat the patient's psychotic symptoms. *Oral haloperidol* - While haloperidol is an **effective antipsychotic**, it is an **oral formulation**. Given the patient's history of **non-compliance** with oral medication (risperidone), switching to another oral antipsychotic, even one as potent as haloperidol, is unlikely to solve the adherence issue, especially in an unstable living situation. - Long-term management requires a strategy that overcomes the compliance barrier. *Oral diazepam* - Diazepam is a **benzodiazepine** primarily used for anxiety, sedation, and seizure control. - It has **no antipsychotic properties** and would not treat the underlying psychotic symptoms of schizophrenia. It would only provide temporary sedation.
Explanation: ***Asociality, flat affect, and alogia*** - This patient exhibits **delusions (persecutory, control)** and **auditory hallucinations**, classic positive symptoms of **schizophrenia**. The question asks about findings "during the course of his illness," which points to the **typical progression of schizophrenia**: patients initially present with **positive symptoms** (as seen in this case) and **over time develop negative symptoms** such as **asociality** (lack of motivation to engage in social interaction), **flat affect** (reduced emotional expression), and **alogia** (poverty of speech). - The disorganized appearance (unwashed hair, clothes on backward) already demonstrates **disorganized behavior**, part of the schizophrenia spectrum. Negative symptoms typically emerge or worsen as the illness progresses, representing the most likely additional findings. *Anhedonia, guilty rumination, and insomnia* - While **anhedonia** and **insomnia** can be seen in schizophrenia, their presence alongside prominent **guilty rumination** would more strongly suggest a **depressive disorder with psychotic features**, rather than primary schizophrenia, especially with the patient's specific, classic psychotic symptoms. - The primary symptoms described (delusions of control, auditory hallucinations) are more characteristic of primary psychotic disorders, and guilty rumination is not a typical feature of schizophrenia progression. *Grandiose delusions, racing thoughts, and pressured speech* - These symptoms are hallmark features of **mania** or a **manic episode with psychotic features**. While psychotic features can occur in bipolar disorder with mania, the patient's specific delusions of being controlled by spies and hearing voices discussing him are more typical of schizophrenia. - The absence of information about elevated mood, increased energy, or decreased need for sleep also makes mania less likely compared to schizophrenia. *Amnesia, multiple personality states, and de-realization* - These symptoms are characteristic of **dissociative disorders**. **Amnesia** and **multiple personality states** (now known as identity alteration in dissociative identity disorder) involve disturbances in memory and identity. - **De-realization** involves feelings of unreality regarding one's surroundings. None of these align with the patient's primary presentation of well-formed delusions and hallucinations characteristic of a psychotic disorder. *Intrusive thoughts, ritualized behaviors, and anxious mood* - These are core features of **obsessive-compulsive disorder (OCD)**. The patient's symptoms are clearly defined as delusions (fixed false beliefs) and hallucinations (perceptions without external stimuli), which are distinct from the ego-dystonic intrusive thoughts and ritualistic compulsions of OCD. - While anxiety may be present in psychotic disorders, the primary presentation here is not dominated by OCD-like symptoms, and these would not be expected to develop as part of schizophrenia's natural course.
Explanation: ***Patient has disorganized thinking*** - The patient's use of **rhyming, nonsensical answers** ("I am fine, pine, dine doc"; "nope, pope, dope doc") despite being able to speak clearly, indicates a breakdown in the logical processing of thoughts. This is a classic example of **disorganized thought process**, often seen in conditions like **schizophrenia**. - **Neologisms** and **word salads** are also forms of disorganized thinking, where the connections between thoughts are loosened or completely absent, making communication difficult to follow. *Patient has disorganized behavior* - **Disorganized behavior** typically refers to unpredictable, socially inappropriate, or bizarre actions, such as odd dress, grimacing, or difficulty performing goal-directed activities. - While the patient's social withdrawal might be a component, his primary symptom described (speech pattern) points more directly to thought disorder rather than overt behavioral disorganization. *Patient has no insight* - **Lack of insight** means the patient does not recognize their illness or the need for treatment, which is evident here ("did not comply with treatment"). - However, disorganized thinking is a more specific and accurate description of the **core symptom** related to his unusual speech pattern, while lack of insight is a consequence or a co-occurring symptom, not the primary cognitive disturbance. *It is associated with a better prognosis* - **Disorganized thinking** is generally associated with a **worse prognosis** in psychotic disorders, particularly schizophrenia. It often indicates more severe cognitive deficits and resistance to treatment. - A better prognosis is typically linked to factors like a later age of onset, acute onset, good premorbid functioning, and the absence of negative symptoms or disorganized thought. *Confrontational psychoeducation would be beneficial* - Since the patient demonstrates **lack of insight** and likely has a significant mental illness, a **confrontational approach** would likely be counterproductive, increasing resistance and distrust. - **Non-confrontational, supportive, and empathetic psychoeducation** is generally recommended for patients with psychotic disorders to build rapport and encourage treatment adherence.
Explanation: ***Clozapine*** - This patient has demonstrated **treatment-resistant schizophrenia**, evidenced by persistent positive symptoms despite trials of haloperidol and risperidone, necessitating a trial of clozapine. - **Clozapine** is an atypical antipsychotic that is uniquely effective for treatment-resistant schizophrenia, especially in patients with a history of **suicidality**. *Olanzapine* - While **olanzapine** is an effective atypical antipsychotic, it is generally considered a first-line or second-line agent, and this patient has already failed two antipsychotics (haloperidol and risperidone). - Its efficacy in **treatment-resistant cases** is not superior to clozapine. *Thioridazine* - **Thioridazine** is a first-generation antipsychotic with a high risk of **QT prolongation** and other cardiac side effects, making it a less safe option. - It is not typically reserved for **treatment-resistant schizophrenia** due to its side effect profile and lack of superior efficacy compared to newer agents. *Chlorpromazine* - **Chlorpromazine** is another first-generation antipsychotic that is not indicated for **treatment-resistant schizophrenia** at this stage. - It carries significant anticholinergic and sedative side effects, similar to thioridazine, and is not significantly more effective than haloperidol for this indication. *Fluphenazine* - **Fluphenazine** is a potent first-generation antipsychotic, often available as a **depot injection** for adherence issues. - However, it is not considered the best next step for **treatment-resistant schizophrenia** after failure of two different classes of antipsychotics.
Explanation: ***Akathisia*** - The patient's inability to sit still, restlessness, pacing, and agitation, especially after initiating **fluphenazine** (a first-generation antipsychotic), are classical symptoms of **akathisia**. - **Akathisia** is a common **extrapyramidal side effect** of antipsychotic medications, characterized by an inner feeling of motor restlessness and a compelling need to move. *Parkinsonism* - While also an extrapyramidal side effect of antipsychotics, **parkinsonism** presents with **bradykinesia**, **rigidity**, and **tremor**, not the constant, agitated movement seen in this patient. - The patient's primary symptom is a subjective feeling of restlessness driving movement, which differs from the objective motor slowing of parkinsonism. *Drug-induced mania* - Drug-induced mania would typically involve symptoms like **elevated mood**, grandiosity, decreased need for sleep (without distress), and racing thoughts, which are not detailed here. - While agitation can be a feature of mania, the specific symptom constellation of inner restlessness and compulsive movement strongly points away from mania. *Inadequately treated schizophrenia* - If schizophrenia were inadequately treated, the patient's psychotic symptoms (e.g., hallucinations, delusions) would likely persist or worsen, which are not described. - The symptoms described are **iatrogenic**, meaning they are a side effect of the medication, rather than a manifestation of the underlying psychiatric illness. *Restless legs syndrome* - **Restless legs syndrome** typically manifests as an irresistible urge to move the legs, often accompanied by unpleasant sensations, primarily occurring in the evening or at night and relieved by movement. - The patient's symptoms are generalized restlessness and agitation, not confined to the legs or specific to time of day, and are directly linked to recent antipsychotic initiation.
Explanation: ***Poor premorbid functioning*** - **Poor premorbid functioning** is a well-established **unfavorable prognostic factor** in schizophrenia, associated with worse long-term outcomes and functional recovery. - This patient demonstrates poor premorbid functioning: he declined from being a college student to being suspended, became increasingly isolated with no friends or social contacts, and presents as unkempt and aloof. - The insidious deterioration over 6 months with prominent negative symptoms (taciturnity, poverty of speech, social withdrawal) further suggests poor premorbid adjustment. *Late onset of illness* - **Late onset** (after age 25-30) is associated with a **better prognosis** because brain development is more complete and there is typically better premorbid functioning. - This is a **favorable**, not unfavorable, prognostic factor. *Presence of mood symptoms* - The presence of **prominent mood symptoms** (depression, mania) in psychotic disorders is associated with a **better prognosis** than pure schizophrenia. - Schizoaffective disorder generally has better outcomes than schizophrenia. - This is a **favorable** prognostic factor. *Good insight into illness* - **Good insight** is a highly **favorable prognostic factor** as it increases treatment adherence and engagement in recovery. - This patient lacks insight, demonstrating disorganized thought and delusions without awareness of illness. *Strong family support* - **Strong family support** is a crucial **favorable prognostic factor**, improving treatment adherence, recovery, and social reintegration. - While the mother is involved, the patient's complete social isolation (no friends or contacts besides mother) suggests limited overall support network.
Explanation: ***Schizoid personality disorder*** - This patient exhibits a pervasive pattern of **detachment from social relationships** and a restricted range of emotional expression, evident in his **lifelong history of being a "loner," lack of emotion** at his mother's death, and indifference to social norms (attending a funeral in inappropriate attire). - Key features like **social isolation**, indifference to praise or criticism, and a preference for solitary activities (repairing electrical appliances) align well with the diagnostic criteria for schizoid personality disorder. *Schizophrenia* - While schizophrenia involves social withdrawal, it is primarily characterized by **psychotic symptoms** such as hallucinations, delusions, and disorganized thought/speech, which are not described in this patient. - The patient's long-standing difficulties with social interaction from childhood, without evidence of a preceding prodromal phase or acute psychotic episodes, makes schizophrenia less likely. *Depressive disorder* - Although the patient recently experienced the death of his mother, his **lack of emotional expression**, long-term history of social detachment, and disinterest in social activities point away from a primary depressive episode. - While social withdrawal can occur in depression, the **pervasive and chronic nature of his isolation** and emotional restrictedness are more indicative of a personality disorder. *Social anxiety disorder* - Individuals with social anxiety disorder desire social interaction but avoid it due to **fear of embarrassment or negative evaluation**, whereas this patient shows a genuine **lack of interest** in social relationships (being a "loner" by choice). - He does not appear anxious about social situations but rather indifferent to them, as evidenced by his casual attitude regarding his attire at the funeral. *Autism Spectrum Disorder* - Although there are some overlaps in social interaction difficulties, autism spectrum disorder typically presents with **restricted, repetitive patterns of behavior, interests, or activities** and often includes communication deficits (e.g., unusual speech patterns, difficulty with non-verbal cues). - While his focus on electrical appliances could be seen as a restricted interest, the primary emphasis in the clinical picture is his **pervasive preference for solitude and emotional detachment**, without clear evidence of the other core diagnostic features of ASD.
Explanation: ***Ziprasidone*** - This patient presents with **worsening psychotic symptoms** (hallucinations) and **anxiety** despite being on fluphenazine, a first-generation antipsychotic. Ziprasidone is a **second-generation antipsychotic (SGA)** that can effectively treat both psychotic symptoms and comorbid anxiety in schizophrenia. - SGAs like ziprasidone are often preferred due to a **lower risk of extrapyramidal symptoms** compared to older antipsychotics like fluphenazine, and their **efficacy in treating negative symptoms and mood disturbances** often seen in schizophrenia. *Fluoxetine* - Fluoxetine is a **selective serotonin reuptake inhibitor (SSRI)** primarily used to treat depression and anxiety disorders. While the patient has anxiety, his primary issue is worsening psychotic symptoms. - Using an antidepressant alone without addressing the underlying psychosis would be insufficient and could potentially exacerbate psychotic symptoms in some individuals. *Chlorpromazine* - Chlorpromazine is a **first-generation antipsychotic (FGA)**, similar to fluphenazine, which the patient is already taking and showing inadequate response. - Switching from one FGA to another FGA like chlorpromazine is unlikely to be more effective and carries a **high risk of extrapyramidal side effects** and sedation, which may further impair the patient's functioning. *Buspirone* - Buspirone is an **anxiolytic** specifically for generalized anxiety disorder. While it can treat anxiety, it offers no benefit for the patient's worsening **hallucinations** and underlying schizophrenia. - It has a slower onset of action and is less effective in acute anxiety or when psychosis is the primary driver of anxiety. *Alprazolam* - Alprazolam is a **benzodiazepine** used for short-term relief of acute anxiety. While it could temporarily alleviate anxiety, it does not address the underlying **psychotic symptoms** which are worsening. - Long-term use of benzodiazepines is discouraged due to risks of **dependence, tolerance**, and potential for worsening cognitive function, which is particularly concerning in a patient with schizophrenia.
Explanation: ***Schizoaffective disorder*** - The patient experienced a **major depressive episode** (anhedonia, tearfulness, frequent talk of death, weight loss) lasting approximately 3 months, followed by **psychotic symptoms** (bizarre delusions) for 2 weeks. - For **schizoaffective disorder**, the key criteria are: (1) mood symptoms present for the **majority** of the total illness duration, and (2) psychotic symptoms for **≥2 weeks in the absence of mood symptoms**. - This case satisfies both: mood symptoms were present for ~3 out of 3.5 months (~85% of illness), and psychotic symptoms have been present for 2 weeks after mood symptoms resolved. - This is **schizoaffective disorder, depressive type**. *Depression with psychotic features* - In **depression with psychotic features**, the psychotic symptoms (delusions or hallucinations) occur **only during** the depressive episode. - The patient's depressive symptoms had **resolved** before the onset of his psychotic symptoms, which rules out this diagnosis. *Cannabis intoxication* - While the patient has a **positive marijuana screen**, his symptoms have been ongoing for **two weeks**, which is inconsistent with acute cannabis intoxication. - The presence of a clear antecedent major depressive episode also points away from this being purely substance-induced. *Schizophrenia with depression* - For a diagnosis of **schizophrenia**, mood symptoms should be present for a **minority** of the total duration of the illness. - In this case, depressive symptoms were present for the **majority** (~85%) of the total illness duration, which distinguishes this from schizophrenia. *Brief psychotic disorder* - **Brief psychotic disorder** is characterized by psychotic symptoms lasting **less than 1 month** with eventual full return to baseline. - While the patient's psychotic symptoms have been present for only 2 weeks so far, the overall clinical picture with a prolonged prior depressive episode and ongoing illness course suggests a more chronic condition consistent with schizoaffective disorder.
Explanation: ***Olanzapine*** - This patient presents with **acute agitation** in the context of **non-compliance** and chronic schizophrenia, making a rapidly acting, sedating antipsychotic beneficial. **Olanzapine** has a significant sedating effect and can be administered via intramuscular (IM) injection for rapid tranquilization, which is crucial given her current level of agitation and the inability to perform a proper physical exam. - **Olanzapine IM** is FDA-approved for acute agitation in schizophrenia and has rapid onset (15-30 minutes), making it highly effective for immediate stabilization. - **Important consideration**: While olanzapine has significant **metabolic side effects** (weight gain, hyperglycemia, dyslipidemia) that are concerning given her diabetes, morbid obesity, and hyperlipidemia, the **immediate priority** in this acute presentation is to stabilize her psychiatric symptoms and agitation. Once stabilized, transition to a medication with better metabolic profile should be considered for long-term management. *Haloperidol* - **Haloperidol** is a first-generation antipsychotic commonly used for acute agitation due to its rapid effect and IM availability. It has **minimal metabolic side effects**, which would be advantageous given her comorbidities. - However, it carries a **high risk of extrapyramidal symptoms (EPS)**, including acute dystonia, akathisia, and parkinsonism, which can be distressing and worsen agitation. It also has risk of **QTc prolongation**, particularly with higher doses or IV administration. - While haloperidol is a reasonable alternative, **olanzapine** provides comparable rapid tranquilization with **greater sedation** and potentially better tolerability in the acute phase, making it preferred for initial stabilization in severely agitated patients. *Clozapine* - **Clozapine** is an antipsychotic reserved for **treatment-resistant schizophrenia** (failed trials of at least two other antipsychotics) due to its superior efficacy in refractory cases. However, it carries a significant risk of **agranulocytosis** and requires weekly blood monitoring initially, making it inappropriate for acute agitation in a non-compliant patient. - Its **slow titration** requirement (to minimize seizure risk) and need for close monitoring make it unsuitable for initial management of acute psychosis and agitation. *Risperidone* - **Risperidone** is a commonly used second-generation antipsychotic but is **less sedating** than olanzapine, making it less ideal for severe acute agitation requiring rapid tranquilization. - While IM risperidone exists (Risperdal Consta), it is a **long-acting depot formulation** designed for maintenance therapy (releases over 2 weeks), not acute agitation management. - It also carries dose-dependent risk of **extrapyramidal symptoms (EPS)** and **hyperprolactinemia**, which may be problematic. *Quetiapine* - **Quetiapine** has significant **sedative properties** due to antihistaminic effects, but it lacks an **immediate-acting IM formulation** for acute agitation (only extended-release oral forms available). - Its **anticholinergic** and **alpha-adrenergic blocking** effects can lead to **orthostatic hypotension** and **tachycardia**, which could be problematic in an acutely agitated patient requiring rapid intervention. - While it has a better metabolic profile than olanzapine, the lack of IM formulation for acute use and slower onset make it less suitable for immediate tranquilization compared to IM olanzapine.
Explanation: ***Loose associations*** - This is characterized by a **lack of logical connection** between thoughts or ideas, leading to a disorganized and incoherent flow of speech. The patient's statements about aliens, her car, the sky, and her mother's cat are **unrelated and lack a clear thematic thread**. - It is a key feature of **thought disorganization** and is commonly seen in psychotic disorders like **schizophrenia**. *Circumstantial speech* - This involves including a **multitude of unnecessary details** before finally arriving at the point or answering the question. - While the patient's speech is disorganized, it does not demonstrate the characteristic meandering yet goal-directed nature of circumstantiality. *Clang associations* - This refers to the **association of words based on their sound** rather than their meaning, often involving rhyming or alliteration. - The patient's statements do not exhibit a pattern of rhyming or sound-based word choices. *Flight of ideas* - This is a rapid, continuous progression from one thought to another, with thoughts often **connected by tangential associations** but still having some discernable link. - Although the patient's thoughts shift rapidly, the connections are not simply tangential; they are largely absent, suggesting a more severe form of disorganization than flight of ideas typically entails. *Thought-blocking* - This is an **abrupt cessation of thought or speech** in the middle of a sentence, often followed by a new and unrelated thought. - The patient's speech flows continuously, albeit incoherently, without sudden stops or breaks.
Explanation: ***Infection*** - The patient has **tardive dyskinesia** and **persistent psychotic symptoms** despite changes in medications. The next best step is to switch to **clozapine**. - **Clozapine** can cause **agranulocytosis**, which increases the risk of serious infections and requires regular monitoring of white blood cell counts. *Anxiolysis* - While some antipsychotics can have anxiolytic effects, it is not the primary side effect or the most concerning one for the "next best step" in this context. - The patient's primary issues are persistent psychosis and tardive dyskinesia, not anxiety that would be specifically targeted as the main side effect. *Dry mouth and dry eyes* - These are common **anticholinergic side effects** associated with many antipsychotics, including clozapine, but they are generally less severe and life-threatening compared to the risk of agranulocytosis. - While unpleasant, they are not the most significant or defining side effect of the "next best step" in managing this patient's complex presentation. *QT prolongation on EKG* - **QT prolongation** is a known cardiac side effect of several antipsychotics, including clozapine. - However, the risk of **agranulocytosis** with **clozapine** is arguably the most critical and distinct side effect requiring stringent monitoring, making it the "next best step" related answer. *Worsening of psychotic symptoms* - The "next best step" would be directed at *improving* psychotic symptoms, not worsening them. **Clozapine** is specifically indicated for **treatment-resistant schizophrenia**. - Worsening psychosis would indicate treatment failure or an adverse reaction, not a typical side effect of the intended beneficial action.
Explanation: ***Schizotypal personality disorder*** - This patient exhibits odd beliefs and **magical thinking** (copper bracelets, crystal amulet, paranormal investigator, astrology), eccentric behavior (stockpiled canned goods for an apocalypse), and **social anxiety** and discomfort with new people, which are characteristic features of schizotypal personality disorder. - Despite the unusual beliefs, his **reality testing is intact**, and he lacks overt psychotic symptoms like hallucinations or delusions, differentiating it from psychotic disorders. *Schizoid personality disorder* - Individuals with schizoid personality disorder show a pervasive pattern of **detachment from social relationships** and a restricted range of emotional expression, often described as showing emotional frigidity. - While this patient has some awkwardness with new people, he has a few close friends, long-standing interests, and is capable of empathy, which is not typical of the **profound social isolation and indifference** seen in schizoid personality disorder. *Schizophrenia* - Schizophrenia is characterized by significant psychotic symptoms such as **delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior**, and negative symptoms (e.g., flattened affect, avolition) that impair functioning. - This patient explicitly denies **depressed mood, anxiety, or hallucinations**, and his thought process is linear with intact reality testing, ruling out active schizophrenia. *Brief psychotic disorder* - Brief psychotic disorder involves the sudden onset of at least one psychotic symptom (delusions, hallucinations, disorganized speech, or grossly disorganized/catatonic behavior) lasting **more than one day but less than one month**, with eventual full return to premorbid functioning. - This patient does not exhibit any **acute psychotic symptoms**; his peculiar beliefs and social discomfiture are long-standing personality traits, not a sudden onset of active psychosis. *Schizophreniform disorder* - Schizophreniform disorder involves symptoms that are identical to schizophrenia but last for a shorter duration, specifically **between one and six months**. - As with schizophrenia, this patient does not demonstrate the core **psychotic symptoms** (delusions, hallucinations, disorganized speech) required for a diagnosis of schizophreniform disorder, and his reality testing remains intact.
Explanation: ***Schizoid personality disorder*** - This patient exhibits key features of **schizoid personality disorder**, including **social detachment**, **restricted emotional expression**, and a **lack of desire for close relationships**. His indifference to his mother's crying and preference for solitary activities (video games) are very characteristic. - While he spends a lot of time playing video games, his statement that "it's okay" when asked about their importance suggests a general lack of strong feelings or passions, which is consistent with the flat affect and anhedonia seen in this disorder. *Antisocial personality disorder* - This disorder is characterized by a **disregard for social norms and the rights of others**, often involving **deceit, manipulation, and impulsivity**. This patient does not show evidence of violating social rules or harming others. - While he may lack empathy (indifference to his mother's crying), the primary features defining antisocial personality disorder, such as a **history of conduct problems** or criminal behavior, are absent. *Paranoid personality disorder* - Individuals with **paranoid personality disorder** exhibit widespread **distrust and suspicion of others' motives**, often interpreting their actions as malevolent. This patient does not display any signs of paranoia or suspiciousness. - His social withdrawal stems from a lack of interest in social relationships rather than fear or distrust of others. *Schizophreniform disorder* - **Schizophreniform disorder** involves psychotic symptoms such as **hallucinations, delusions, disorganized speech, or grossly disorganized/catatonic behavior**, lasting from one to six months. This patient's thought process is described as organized and logical, and he presents no psychotic features. - His symptoms are primarily related to personality traits and social functioning, without evidence of the more severe disruptions in thought and perception seen in psychotic disorders. *Avoidant personality disorder* - **Avoidant personality disorder** is characterized by **social inhibition, feelings of inadequacy, and hypersensitivity to negative evaluation**, leading to avoidance of social interaction despite a desire for connection. - This patient's social withdrawal is due to a **lack of interest in relationships** rather than fear of rejection or inadequacy; he states he *prefers* to be on his own.
Explanation: ***Haloperidol*** - The patient's repetitive **lip-smacking** and **tongue-sweeping** behaviors are characteristic of **tardive dyskinesia**, an involuntary movement disorder. - **First-generation antipsychotics** (FGAs) like haloperidol are highly associated with tardive dyskinesia due to their strong **D2 receptor blockade**. *Clozapine* - Clozapine is a **second-generation antipsychotic** (SGA) known for its very low risk of **tardive dyskinesia**. - It is often used for **treatment-resistant schizophrenia** and carries a risk of agranulocytosis. *Risperidone* - Risperidone is an **SGA** that has a **higher risk of extrapyramidal side effects** and tardive dyskinesia compared to other SGAs, but generally less than FGAs. - The prominent and classic presentation of tardive dyskinesia points more strongly to an FGA. *Olanzapine* - Olanzapine is an **SGA** with a relatively low risk of **tardive dyskinesia** but is associated with significant **metabolic side effects** (weight gain, dyslipidemia, hyperglycemia). - Its side effect profile generally does not match the described neurological symptoms as the most likely cause. *Quetiapine* - Quetiapine is an **SGA** well-known for its very **low risk of extrapyramidal side effects** and tardive dyskinesia due to its weak D2 receptor binding and rapid dissociation. - It is often favored for patients who are sensitive to motor side effects.
Explanation: ***Clozapine*** - **Clozapine** is the drug of choice for **treatment-resistant schizophrenia**, defined as inadequate response to two or more different antipsychotics (including at least one second-generation agent) given at adequate doses and for sufficient durations. - Its unique mechanism of action, involving dopamine and serotonin receptors, makes it effective in about 30-50% of patients who do not respond to other antipsychotics. *Clonidine* - **Clonidine** is primarily an **alpha-2 adrenergic agonist** used for hypertension, ADHD, and substance withdrawal, not a primary treatment for schizophrenia. - It does not have significant antipsychotic properties to address hallucinations and delusions. *Haloperidol* - **Haloperidol** is a **first-generation antipsychotic** that the patient's prior treatment with olanzapine, quetiapine, and risperidone (all second-generation antipsychotics) already demonstrated failure with similar mechanisms of action. - Since the patient has already failed multiple antipsychotics, switching to another typical antipsychotic is unlikely to be effective. *Aripiprazole* - **Aripiprazole** is another **second-generation antipsychotic** that works similarly to the ones the patient has already failed (olanzapine, quetiapine, risperidone). - Given the lack of response to previous trials, it is unlikely to provide superior efficacy in this case of treatment-resistant schizophrenia. *Cognitive behavioral therapy* - **Cognitive behavioral therapy (CBT)** is a helpful adjunct to pharmacotherapy for schizophrenia, but it is **not a monotherapy** for acute psychotic symptoms or treatment-resistant cases. - While supportive and beneficial for managing symptoms and improving coping skills, it does not replace the need for effective pharmacological treatment in resistant schizophrenia.
Explanation: ***Clozapine*** - The patient exhibits severe **agranulocytosis** (WBC count 1,100/mm³ with 5% neutrophils, indicating an absolute neutrophil count of 55/mm³), a life-threatening side effect uniquely associated with **clozapine** among antipsychotics. - Given his history of **refractory schizophrenia** (implying resistance to other antipsychotics), clozapine is the most likely antipsychotic he would be prescribed. *Chlorpromazine* - This first-generation antipsychotic can cause adverse effects like **sedation, orthostatic hypotension, and anticholinergic symptoms**, but severe agranulocytosis is rare. - While it can cause leukopenia, the profound agranulocytosis seen in the patient is not characteristic of chlorpromazine. *Risperidone* - Atypical antipsychotic known for side effects such as **hyperprolactinemia, weight gain, and metabolic syndrome**. - Though it can cause neutropenia or leukopenia, it rarely causes the severe agranulocytosis observed here. *Haloperidol* - A high-potency first-generation antipsychotic primarily associated with **extrapyramidal symptoms (EPS)** and **neuroleptic malignant syndrome (NMS)**. - It does not typically cause the severe bone marrow suppression, specifically agranulocytosis, observed in this patient. *Olanzapine* - This atypical antipsychotic is associated with significant **weight gain, sedation, and metabolic syndrome**. - While it can cause some hematologic abnormalities, it is not known to cause severe agranulocytosis to the same extent as clozapine.
Explanation: ***Schizophrenia*** - The patient's presentation with **delusions of persecution and thought broadcasting**, accompanied by **disjointed, perseverative thinking**, and **flat affect** for 8 months, is highly indicative of schizophrenia. - Schizophrenia is characterized by a combination of positive symptoms (delusions, hallucinations, disorganized speech), negative symptoms (flat affect, social withdrawal), and cognitive symptoms (disorganized thinking) lasting for at least 6 months. *Delusional disorder* - Delusional disorder is characterized by the presence of **non-bizarre delusions for at least 1 month** without other significant psychotic symptoms or marked impairment in functioning. - The patient's symptoms include **disorganized thinking and flat affect**, which are not typical of delusional disorder and suggest a broader psychotic illness. *Paranoid personality disorder* - Characterized by a pervasive distrust and suspicion of others, where their motives are interpreted as malevolent, but **without the presence of frank delusions or other psychotic symptoms**. - The patient is experiencing **fixed, false beliefs (delusions)** involving mind reading and foreign intelligence, which goes beyond the pervasive distrust seen in paranoid personality disorder. *Schizophreniform disorder* - Schizophreniform disorder presents with symptoms identical to schizophrenia, but the **duration is between 1 and 6 months**. - Since the patient's symptoms have been present for **8 months**, it exceeds the diagnostic criteria for schizophreniform disorder, making schizophrenia a more likely diagnosis. *Schizoid personality disorder* - Characterized by a pervasive pattern of **detachment from social relationships** and a restricted range of expression of emotions in interpersonal settings. - While the patient exhibits social withdrawal, this condition does **not involve delusions, disorganized thinking, or other psychotic features**.
Explanation: ***Akathisia*** - **Akathisia** is a common extrapyramidal symptom characterized by **inner restlessness** and an inability to sit still, often leading to fidgeting and pacing. - This symptom frequently arises after initiating or increasing the dose of **antipsychotic medications**, particularly **first-generation antipsychotics**, consistent with the patient's recent schizophrenia diagnosis and treatment. *Essential tremor* - **Essential tremor** is typically a kinetic tremor (tremor with movement) or postural tremor (tremor when holding a posture) that primarily affects the hands and head, rather than an intense feeling of inner restlessness. - While it can cause discomfort, it doesn't manifest as an inability to sit or lie down due to an internal urge for constant movement like akathisia. *Drug-induced parkinsonism* - **Drug-induced parkinsonism** presents with symptoms like **bradykinesia (slow movement)**, rigidity, and resting tremor, mimicking Parkinson's disease. - It does not primarily involve the subjective feeling of restlessness or the inability to sit or lie down, which is characteristic of akathisia. *Psychotic agitation* - **Psychotic agitation** is a state of severe restlessness and heightened activity often accompanied by disordered thinking, irritability, and potentially aggression, typically stemming from the underlying psychotic disorder itself. - While psychosis can involve restlessness, akathisia is a specific drug-induced movement disorder with a characteristic internal sensation of unease, distinct from the broader disorganization seen in general psychotic agitation. *Acute dystonia* - **Acute dystonia** involves sustained or repetitive muscle contractions, leading to abnormal, often painful, postures or movements, such as torticollis or oculogyric crisis. - It does not explain the patient's generalized restlessness and inability to remain still, which points more towards akathisia rather than specific muscle spasms.
Diagnostic criteria and subtypes
Practice Questions
Positive symptoms
Practice Questions
Negative symptoms
Practice Questions
Cognitive symptoms
Practice Questions
Prodromal phase and early intervention
Practice Questions
Neurobiological theories of schizophrenia
Practice Questions
Genetics of schizophrenia
Practice Questions
Neuroimaging findings
Practice Questions
First-generation antipsychotics
Practice Questions
Second-generation antipsychotics
Practice Questions
Treatment-resistant schizophrenia
Practice Questions
Psychosocial rehabilitation
Practice Questions
Long-acting injectable antipsychotics
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free